Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yuki Kakio"'
Autor:
Nobuo Kajitani, Haruhito A. Uchida, Isao Suminoe, Yuki Kakio, Masashi Kitagawa, Hajime Sato, Jun Wada
Publikováno v:
Journal of International Medical Research, Vol 46 (2018)
Objective We aimed to investigate the relationships among chronic kidney disease (CKD), symptomatic ischaemic stroke, and carotid atherosclerosis. Methods We enrolled 455 patients who underwent carotid ultrasonography in our hospital, including 311 p
Externí odkaz:
https://doaj.org/article/5e5a52a84dba43fcbbced0126c508f66
Autor:
Hidemi Takeuchi, Michihiro Okuyama, Haruhito A Uchida, Yuki Kakio, Ryoko Umebayashi, Yuka Okuyama, Yasuhiro Fujii, Susumu Ozawa, Masashi Yoshida, Yu Oshima, Shunji Sano, Jun Wada
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164015 (2016)
Chronic kidney disease (CKD) and diabetes mellitus (DM) are considered as risk factors for cardiovascular diseases. The purpose of this study was to clarify the relationship of CKD and DM with the presence of abdominal aortic aneurysm (AAA).We enroll
Externí odkaz:
https://doaj.org/article/82b8ba10764542d09892307802c3db4e
Autor:
Yoshitaka Morita, Yuki Kakio, Yoshiko Hada, Tomoyuki Mukai, Fumiaki Kojima, Nozomu Otaka, Hidemi Takeuchi, Masashi Yoshida, Jun Wada, Haruhito A. Uchida
Publikováno v:
Clinical Science. 134:2771-2787
The aim of the present study was to examine whether inhibition of Interleukin (IL)-6 signaling by MR16-1, an IL-6 receptor antibody, attenuates aortitis, cardiac hypertrophy, and arthritis in IL-1 receptor antagonist deficient (IL-1RA KO) mice. Four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af591b5552347dc3a296141a7f31b7b
https://doi.org/10.1042/cs20201036
https://doi.org/10.1042/cs20201036
Autor:
Taichi Murakami, Saki Akazawa, Shigeaki Nishimura, Iku Ninomiya, Naoko Kukida, Yutaka Yanagihara, Shiro Fujikata, Kenjiro Okamoto, Sadamu Yamashi, Seiji Asai, Keigo Nishida, Takeshi Miyake, Hiroyuki Watatani, Seiya Utsunomiya, Masaharu Kan, Yuki Kakio
Publikováno v:
Nihon Toseki Igakkai Zasshi. 53:139-145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::006d633b67e477d76a76d5d2cf8ea377
https://doi.org/10.4009/jsdt.53.139
https://doi.org/10.4009/jsdt.53.139
Autor:
Yoshiko Hada, Nozomu Otaka, Haruhito A. Uchida, Michihiro Okuyama, Yasufumi Sato, Shingo Kasahara, Katsuyuki Tanabe, Alan Daugherty, Venkateswaran Subramanian, Yuki Kakio, Jun Wada, Yasuhiro Fujii, Ryoko Umebayashi
Publikováno v:
Circulation Reports
Background: Chronic angiotensin II (AngII) infusion promotes ascending aortic dilation in C57BL/6J mice. Meanwhile, vasohibin-2 (VASH2) is an angiogenesis promoter in neovascularization under various pathologic conditions. The aim of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a2d96da419266fecaa96d6d8cdfddf
https://doi.org/10.1253/circrep.cr-19-0008
https://doi.org/10.1253/circrep.cr-19-0008
Autor:
Hidemi Takeuchi, Hiromi Rakugi, Michihiro Okuyama, Yuka Okuyama, Shingo Kasahara, Hitoshi Sugiyama, Kentaro Wada, Yuki Kakio, Ken Sugimoto, Jun Wada, Haruhito A. Uchida, Ryoko Umebayashi
Publikováno v:
Geriatrics & Gerontology International. 18:1597-1602
Aim Since 1998, the leading cause of chronic hemodialysis in Japan has been diabetic nephropathy. Diabetes mellitus is known to be a risk factor for frailty, but it still remains unknown whether diabetic nephropathy is associated with frailty in chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7bb7ecc0048d2cf8bd39e011a9e3310
https://doi.org/10.1111/ggi.13534
https://doi.org/10.1111/ggi.13534
Autor:
Hitoshi Sugiyama, Yuka Okuyama, Shingo Kasahara, Hidemi Takeuchi, Michihiro Okuyama, Hiromi Rakugi, Ken Sugimoto, Kentaro Wada, Yuki Kakio, Ryoko Umebayashi, Jun Wada, Haruhito A. Uchida
Publikováno v:
Vascular. 26:425-431
ObjectivesThe clinical condition of frailty is a common problem in the elderly population. However, the relationship between peripheral artery disease and frailty in hemodialysis patients remains unknown. The aim of this study was to identify the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd138aff6a26045f694618a5ee30e9e
https://doi.org/10.1177/1708538118756690
https://doi.org/10.1177/1708538118756690
Autor:
Kenichiro Asano, Hidemi Takeuchi, Yuki Kakio, Jun Wada, Hironobu Tokumasu, Masaki Fukushima, Hitoshi Sugiyama, Noriaki Shimada, Yasuhiro Onishi, Haruhito A. Uchida
Publikováno v:
Nephrology.
Aim Deteriorated health-related quality of life (HRQOL) is associated with increased risk for death in both chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients; however, the impact of HRQOL on CKD progression is not well investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d9310718f3f9bb86d5a85a1ccaa6e2
https://doi.org/10.1111/nep.13515
https://doi.org/10.1111/nep.13515
Autor:
Yuka Okuyama, Hidemi Takeuchi, Ryoko Umebayashi, Hiroyuki Watatani, Hitoshi Sugiyama, Yohei Maeshima, Jun Wada, Yuki Kakio, Haruhito A. Uchida
Publikováno v:
International Journal of Nephrology and Renovascular Disease
Yuki Kakio,1 Haruhito A Uchida1,2Hidemi Takeuchi,1 Yuka Okuyama,1 Ryoko Umebayashi,1 Hiroyuki Watatani,1 Yohei Maeshima,1 Hitoshi Sugiyama,1 Jun Wada11Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76953e393ed5a0084e0b2eb8ce70089
https://pubmed.ncbi.nlm.nih.gov/31308723
https://pubmed.ncbi.nlm.nih.gov/31308723
Autor:
Jun Wada, Ryoko Umebayashi, Toshiyuki Iwahori, Yuka Okuyama, Katsuyuki Miura, Haruhito A. Uchida, Yuki Kakio, Hirotsugu Ueshima, Masashi Kitagawa, Hiroyoshi Segawa, Hitoshi Sugiyama, Ayako Kato, Hidemi Takeuchi
Publikováno v:
Journal of human hypertension. 33(4)
This study aimed to clarify the relationship between repeated measurements of casual (spot) and 24-h urinary sodium-to-potassium (Na/K) ratios in patients with chronic kidney disease (CKD). A total of 61 inpatients with CKD, 31 in stage 1-3 (eGFR [es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03c317397ce12eaa822dd1a28d89b1b
https://pubmed.ncbi.nlm.nih.gov/30443006
https://pubmed.ncbi.nlm.nih.gov/30443006